{
    "title": "US approves Regeneron antibody treatment given to Trump",
    "url": "https://www.dailymail.co.uk/wires/afp/article-8974353/US-approves-Regeneron-antibody-treatment-given-Trump.html",
    "date": "2020-11-22",
    "keywords": [
        "drug",
        "covid19",
        "antibody",
        "regeneron",
        "virus",
        "system",
        "treatment",
        "therapy",
        "emergency",
        "fda",
        "immune",
        "food",
        "administration",
        "president",
        "risk",
        "room",
        "hospitalization",
        "step",
        "access",
        "approval",
        "eua",
        "sarscov2",
        "percent",
        "end",
        "government",
        "sign",
        "oak",
        "maryland",
        "trump",
        "regulator",
        "saturday",
        "disease",
        "light",
        "drugmaker",
        "regencov2",
        "combination",
        "burden",
        "health",
        "care",
        "hahn",
        "commissioner",
        "schleifer",
        "ceo",
        "move",
        "fight",
        "highrisk",
        "course",
        "infection",
        "use",
        "status",
        "everyone",
        "response",
        "surface",
        "protein",
        "trial",
        "variety",
        "obesity",
        "age",
        "placebo",
        "company",
        "november",
        "outofpocket",
        "cost",
        "program",
        "dose",
        "milligrams",
        "total",
        "infusion",
        "development",
        "operation",
        "speed",
        "class",
        "month",
        "ebola",
        "case",
        "mouse",
        "human",
        "lab",
        "order",
        "mass",
        "pfizer",
        "moderna",
        "work"
    ],
    "category": [
        "wires",
        "afp"
    ]
}